PHENOGENOMICS CORPORATION

Serial Number 76443181
606

Registration Progress

Application Filed
Aug 23, 2002
Under Examination
May 11, 2004
Approved for Publication
Jan 28, 2004
Published for Opposition
Feb 17, 2004
Registered

Trademark Image

PHENOGENOMICS CORPORATION

Basic Information

Serial Number
76443181
Filing Date
August 23, 2002
Published for Opposition
February 17, 2004
Abandonment Date
November 12, 2004
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 12, 2004
Classes
009

Rights Holder

PhenoGenomics Corporation

03
Address
22026 20th Ave. SE, Suite 101
Bellevue, WA 98021

Ownership History

PhenoGenomics Corporation

Original Applicant
03
Bellevue, WA

PhenoGenomics Corporation

Owner at Publication
03
Bellevue, WA

Legal Representation

Attorney
Patrick J.S. Inouye

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description
Oct 18, 2006 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 18, 2006 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2005 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Feb 1, 2005 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 11, 2004 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 17, 2004 PUBO A PUBLISHED FOR OPPOSITION
Jan 28, 2004 NPUB O NOTICE OF PUBLICATION
Dec 9, 2003 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 12, 2003 CFIT O CASE FILE IN TICRS
Sep 12, 2003 MAIL I PAPER RECEIVED
Sep 12, 2003 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2003 CNFR O FINAL REFUSAL MAILED
Apr 28, 2003 MAIL I PAPER RECEIVED
Apr 28, 2003 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2002 CNRT F NON-FINAL ACTION MAILED
Nov 13, 2002 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 009
Computer hardware and software for identifying, evaluating, modeling, and archiving protein and nucleotide sequences, and for accessing on-line protein and nucleotide database repositories used in performing biopharmaceutical research and for providing biopharmaceutical technical and information consulting services
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
009

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CORPORATION"